Home › AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank
 

Keywords :   


AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank

2016-03-25 07:39:57| Biotech - Topix.net

The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. Deutsche Bank's price objective suggests a potential upside of 43.33% from the stock's current price.

Tags: price bank cut target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Eastern North Pacific Tropical Weather Outlook
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
More »